Abstract
Xeroderma pigmentosum (XP) is an autosomal recessive disease characterized by solar sensitivity, photophobia, early onset of freckling, and solar-induced cutaneous neoplastic changes. Management of patients with XP is a therapeutic challenge as they usually develop multiple cutaneous malignancies, making surgical therapy difficult, and continue to form skin malignancies at a high rate. We describe a 30-year-old Chinese man with XP who had been previously treated with excision and dermatoplasty. Upon recurrence of multiple superficial, ulcerative, and pigmented lesions, imiquimod 5% cream was recommended for 4 months. His multiple facial lesions demonstrated an excellent response to topical imiquimod 5% cream with minor side effects. This favorable response indicates that topical application of imiquimod 5% cream is an effective means of treating multiple basal cell carcinomas in XP.
References
Mar 4, 2000·Journal of Dermatological Science·J E Cleaver
May 8, 2001·Photodermatology, Photoimmunology & Photomedicine·S Moriwaki, K H Kraemer
Jun 26, 2002·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Noah Kawika Weisberg, Matthew Varghese
Nov 18, 2003·The British Journal of Dermatology·E NagoreC Guillen
Jan 19, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·B EmmertS Emmert
Jul 26, 2011·The Journal of Dermatological Treatment·Francesco LacarrubbaGiuseppe Micali
Nov 3, 2011·Orphanet Journal of Rare Diseases·Alan R LehmannMiria Stefanini
Jan 6, 2012·The Journal of Investigative Dermatology·John J DiGiovanna, Kenneth H Kraemer
Jul 5, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·E A W WolberinkM J P Gerritsen
Jan 9, 2013·Dermatology : International Journal for Clinical and Investigative Dermatology·A M Skaria
May 1, 2013·The British Journal of Dermatology·K M McKayV G Prieto
May 21, 2013·The Lancet Oncology·Aimée H M M AritsNicole W J Kelleners-Smeets
Dec 18, 2013·The Lancet Oncology·John T Lear
Dec 18, 2013·The Lancet Oncology·Fiona Bath-HextallUNKNOWN Surgery versus Imiquimod for Nodular Superficial basal cell carcinoma (SINS) study group
Jan 25, 2014·TheScientificWorldJournal·Subhash MareddyPreethi Balan
Citations
Feb 18, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Mareike AlterRalf Gutzmer
Aug 20, 2015·Indian Journal of Pharmacology·Aditya Kumar Bubna
Jan 30, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·I LatourA Torrelo
Dec 1, 2018·British Journal of Pharmacology·Rosella AbetiPaola Giunti
May 14, 2016·G3 : Genes - Genomes - Genetics·Lu LiuYong Cui
Mar 4, 2017·Case Reports in Medicine·Esteban Uribe-BojaniniAlicia María Cock-Rada
Jul 1, 2018·American Journal of Clinical Dermatology·Amanda F NahhasHenry W Lim
Dec 18, 2020·Dermatologic Therapy·Qiaochu ZhouWei Wang
Mar 27, 2021·Indian Journal of Dermatology, Venereology and Leprology·Fernando Antônio Gomes de AndradeLydia Masako Ferreira